glp-1 guidelines Revolutionizing obesity treatment: The emerging role of receptor agonists and next-generation pharmacotherapies How Do I Prescribe GLP-1

The study published in Obesity Science and Practice that Jay referenced in our conversation found that 81% of employees had a worse perception of their employer after losing GLP-1 coverage, and 18% considered finding a new job as a direct result

SeekPeptides provides comprehensive guides for interpreting these markers and understanding how they change during GLP-1 therapy, helping members make informed decisions about their health journey

The FDA includes a warning about medullary thyroid carcinoma and advises against use in individuals with a family history of the disease or a family history of MEN 2

Research consistently shows that a significant portion of lost weight is regained when treatment is stopped

Patients taking both Zepbound and an SGLT2 inhibitor may incorrectly attribute infections to Zepbound rather than the SGLT2 inhibitor